| 产品名称 | GW9662,PPARγ拮抗剂 |
|---|---|
| 英文名称 | GW9662 |
| 别名 | 2-氯-5-硝基苯甲酰苯胺;2-氯-5-硝基-N-苯基苯甲酰胺 |
| 英文别名 | GW 9662;GW-9662;2-Chloro-5-nitro-N-phenylbenzamide |
| 规格或纯度 | ≥98% |
| 运输条件 | 冰袋运输 |
| 生化机理 | GW 9662 is a selective, irreversible, and effective peroxisome proliferator activated receptor-γ (PPARγ) antagonist. PPARγ research demonstrates that GW 9662 covalently modifies Cys(285) and does not affect transcription of full-length PPARα and PPARδ. GW 9662 has been shown to block Rosiglitazone mediated activation of PPARγ, and improve growth inhibition induced by Rosiglitazone in breast tumor cell research. Additionally, reports indicate that GW 9662 blocks the protective activity of lipopolysaccharide, LPS, and acts as an agonist for the farnesoid X receptor (FXR) and pregnane X receptor (PXR) nuclear receptors.Selective PPARγ antagonist (IC 50 values are 3.3, 32, >1000 nM for PPARγ, PPARα and PPARδ respectively). Apoptotic and antimetastatic activity in vitro . |
GW9662是一种选择性PPAR拮抗剂,作用于PPARγ,IC50为3.3 nM,作用于PPARγ比作用于PPARα和PPARδ选择性强100到1000倍。A selective, irreversible, and effective PPARγ antagonist that also acts as a FXR and PXR agonist.
GW9662 is a selective PPAR antagonist for PPARγ with IC50 of 3.3 nM, with at least 100 to 1000-fold functional selectivity in cells with PPARγ versus PPARα and PPARδ.
A selective, irreversible, and effective PPARγ antagonist that also acts as a FXR and PXR agonist.
| 标识符号 | GHS07 |
|---|---|
| 警示性声明 | P305+P351+P338,P280 |
| 危害声明 | H319,H317 |
| WGK | 3 |
| CAS编号 | 22978-25-2 |
|---|---|
| 溶解性 | Soluble in DMSO (26 mg/ml), methanol, 100% ethanol (10 mg/ml), DMF (~35 mg/ml), and 1:2 DMF : PBS (PH=7.2) (~0.5 mg/ml). Insoluble in water. |
| 储存温度 | 2-8°C储存 |
| MDL号 | MFCD01215270 |
| 分子量 | 276.68 |
| 分子式 | C13H9ClN2O3 |
| 品牌 | 阿拉丁 |
| 备注 | 10mg、50mg卖完停产,不再备货,如果有可能,您尽量在同一天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
| PubChem CID | 644213 |